common.study.topics.clinical

ERG Components in Schizophrenia and Bipolar Disorder Type I

common.study.values.description

ERG Components in Schizophrenia and Bipolar Disorder Type I

This study will further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis. The prediction models are diaMentis proprietary software used as an ERG-based diagnostic test (classified as a Software as Medical Device, SaMD) to support the diagnosis of schizophrenia and bipolar disorder type I. They involve the processing and analysis of specific retinal biosignatures (RSPA) with the support of statistical and mathematical modelling processes e.g. machine learning and statistical learning.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - ERG assessment (RSPA)

Processing and analysis of retinal signals

participant.views.study.view.additional

participant.views.study.view.scientific-title

Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I

common.study.values.clinical-trial-id

NCT03788811

participant.views.study.view.id

e73Owe